These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4062141

  • 1. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
    Douvier JJ, Vergeret J, Taytard A, Brottier E, Domblides P, Dubos F, Freour P.
    Ann Med Interne (Paris); 1985; 136(5):416-8. PubMed ID: 4062141
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pleural effusion induced by bromocriptine].
    Diot E, Diot P, Le Rolland A, Jonville AP, Lasfargues G, Lemarie E, Lavandier M, Guilmot JL.
    Rev Mal Respir; 1990; 7(2):175-7. PubMed ID: 2320790
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
    Bøttcher J, Grøn U.
    Ugeskr Laeger; 1981 Oct 05; 143(41):2648-9. PubMed ID: 7303288
    [No Abstract] [Full Text] [Related]

  • 7. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
    Debove P, Simon F, Vaylet F, Renard JL, L'Her P.
    Ann Med Interne (Paris); 1998 Apr 05; 149(3):167-71. PubMed ID: 11490541
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
    Knoop C, Mairesse M, Lenclud C, Gevenois PA, De Vuyst P.
    Eur Respir J; 1997 Dec 05; 10(12):2898-901. PubMed ID: 9493681
    [Abstract] [Full Text] [Related]

  • 14. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
    Korczyn AD, Brooks DJ, Brunt ER, Poewe WH, Rascol O, Stocchi F.
    Mov Disord; 1998 Jan 05; 13(1):46-51. PubMed ID: 9452325
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment].
    Saura J, Aguilar M, Alió J.
    Neurologia; 1991 Nov 05; 6(9):331-3. PubMed ID: 1809340
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
    Rascol A, Montastruc JL, Guiraud-Chaumeil B, Clanet M.
    Rev Neurol (Paris); 1982 Nov 05; 138(5):401-8. PubMed ID: 7146724
    [Abstract] [Full Text] [Related]

  • 20. Rounded atelectasis and respiratory compromise secondary to pergolide use.
    Bloom CI, Wilson GE.
    Respirology; 2009 Aug 05; 14(6):906-7. PubMed ID: 19659834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.